Wednesday June 3, 07:59 AM
Almirall gets FDA approval for migraine drug
MADRID, June 3 (Reuters) - Spanish pharmaceutical firm Almirall (Madrid: ALM.MC - news) on Wednesday said its Almotriptan migraine drug had gained U.S. Food and Drug Administration approval for adolescents.
(Reporting by Tracy Rucinski; Editing by Andrew Hay)
Send Article by Email
Send Article by IM
Blog This with Y! 360
Printable View
